Valuation: North China Pharmaceutical Company.Ltd

Market Cap 8B 1.2B 1.07B 985M 896M 1.68B 114B 1.71B 11.76B 4.74B 60.07B 4.51B 4.42B 190B P/E 2024
69.9x
P/E 2025 51.7x
Enterprise Value 17.67B 2.66B 2.37B 2.18B 1.98B 3.71B 252B 3.79B 26B 10.48B 133B 9.97B 9.76B 419B EV / Sales 2024
1.89x
EV / Sales 2025 2.07x
Free-Float
43.52%
Yield 2024
0.58%
Yield 2025 0.63%
1 day+2.42%
1 week-4.70%
Current month+2.42%
1 month-6.43%
3 months-3.32%
6 months-10.56%
Current year-15.73%
1 week 4.43
Extreme 4.43
4.84
1 month 4.43
Extreme 4.43
6.9
Current year 4.11
Extreme 4.11
6.9
1 year 4.11
Extreme 4.11
6.9
3 years 3.83
Extreme 3.83
7.46
5 years 3.83
Extreme 3.83
13.45
10 years 3.83
Extreme 3.83
20.24
Manager TitleAgeSince
Chief Executive Officer 55 28/11/2025
Director of Finance/CFO 46 10/04/2024
Investor Relations Contact 45 -
Director TitleAgeSince
Chairman 49 22/03/2016
Director/Board Member 53 23/04/2021
Director/Board Member 54 12/10/2022
Date Insider Type Main position Quantity % Market Cap. Importance
25/2/25 Buy

Chairman

1,600 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+2.42%-4.70%-22.33%-22.72% 1.17B
-0.46%+10.31%+57.38%+143.15% 1,263B
-0.97%+1.60%+45.26%+80.09% 658B
-2.05%+0.73%+36.27%+101.62% 521B
-1.54%+0.18%+53.06%+66.79% 391B
-0.78%+5.51%+79.85%+44.25% 369B
-1.69%+3.17%+32.18%+55.35% 307B
-0.72%+7.83%+12.10%+33.76% 290B
-0.12%+4.68%+57.09%+74.59% 252B
-0.21%+7.34%+39.56%+109.69% 212B
Average -0.47%+5.22%+39.04%+68.66% 426.31B
Weighted average by Cap. -0.79%+6.60%+48.66%+93.26%

Financials

2024 2025
Net sales 9.87B 1.48B 1.32B 1.22B 1.11B 2.07B 140B 2.11B 14.52B 5.85B 74.15B 5.57B 5.45B 234B 9.24B 1.39B 1.24B 1.14B 1.04B 1.94B 132B 1.98B 13.6B 5.48B 69.43B 5.22B 5.1B 219B
Net income 127M 19.09M 17.05M 15.64M 14.23M 26.68M 1.81B 27.21M 187M 75.32M 954M 71.66M 70.14M 3.01B 183M 27.52M 24.57M 22.55M 20.51M 38.46M 2.61B 39.22M 269M 109M 1.38B 103M 101M 4.34B
Net Debt 9.79B 1.47B 1.31B 1.21B 1.1B 2.06B 139B 2.1B 14.4B 5.81B 73.55B 5.52B 5.41B 232B 9.67B 1.45B 1.3B 1.19B 1.08B 2.03B 138B 2.07B 14.23B 5.74B 72.68B 5.46B 5.34B 230B
Projected Income Statement - Annual - North China Pharmaceutical Company.Ltd
Logo North China Pharmaceutical Company.Ltd
North China Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceutical products. The Company's main products include anti-infective drugs, nephrology and immunomodulatory drugs, biotechnology drugs, cardiovascular and cerebrovascular and immunomodulatory agents, vitamins and health consumer products, nervous and blood system drugs, pharmaceutical intermediates, anti-epidemic drugs, pesticides and Veterinary drugs. The Company is also engaged in pharmaceutical and other logistics trade pharmaceuticals. The Company's products are mainly used in chemical pharmaceuticals, modern biotechnology drugs, vitamins and health consumer products, bioagricultural and veterinary drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.
Employees
9,972
Date Price Change Volume
02/11/26 CN¥4.660 +2.42% 51,412,700
30/10/26 CN¥4.550 +0.22% 66,688,399
29/10/26 CN¥4.540 -3.40% 55,498,233
28/10/26 CN¥4.700 0.00% 69,717,768
27/10/26 CN¥4.700 -1.88% 60,167,055

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - North China Pharmaceutical Company.Ltd
  1. Stock Market
  2. Stocks
  3. 600812 Stock